【结 构 式】 |
【分子编号】44867 【品名】1H-imidazo[4,5-b]pyridine 【CA登记号】 |
【 分 子 式 】C6H5N3 【 分 子 量 】119.12592 【元素组成】C 60.5% H 4.23% N 35.27% |
合成路线1
该中间体在本合成路线中的序号:(XVIII)Intermediate (XIV) can be obtained as follows: Bromination of methyl cinnamate (XV) with Br2 in CH2Cl2 provides 2,3-dibromo-3-phenylpropanoate (XVI), which is then converted into alpha-bromocinnamic ester (XVII) by reaction with Et3N in refluxing toluene. Treatment of (XVII) with imidazopyridine (XVIII) and NaH in DMF affords derivative (XIX), which is then hydrolyzed by treatment with NaOH in MeOH to furnish carboxylic acid (XX). Finally, (XX) reacts with carbonylditriazole in DMF to give the target intermediate (XIV).
【1】 Hemmerle, H.; Schubert, G.; Burger, H.-J.; Herling, A.; Efendic, S. (Aventis SA); Cyclohexane derivs., processes for their preparation and their use as glucose-6-phosphatase inhibitors. CA 2149007; CA 4416433; EP 0682024; JP 1995330767; US 5739147 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XIV) | 44863 | C17H12N6O | 详情 | 详情 | ||
(XV) | 23888 | methyl (E)-3-phenyl-2-propenoate | 103-26-4 | C10H10O2 | 详情 | 详情 |
(XVI) | 44865 | methyl 2,3-dibromo-3-phenylpropanoate | C10H10Br2O2 | 详情 | 详情 | |
(XVII) | 44866 | methyl (Z)-2-bromo-3-phenyl-2-propenoate | C10H9BrO2 | 详情 | 详情 | |
(XVIII) | 44867 | 1H-imidazo[4,5-b]pyridine | C6H5N3 | 详情 | 详情 | |
(XIX) | 44868 | methyl (Z)-3-(1H-imidazo[4,5-b]pyridin-1-yl)-3-phenyl-2-propenoate | C16H13N3O2 | 详情 | 详情 | |
(XX) | 44869 | (Z)-3-(1H-imidazo[4,5-b]pyridin-1-yl)-3-phenyl-2-propenoic acid | C15H11N3O2 | 详情 | 详情 | |
(XXI) | 44870 | di(1H-1,2,4-triazol-1-yl)methanone | C5H4N6O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)The intermediate 1-substituted imidazopyridine (III) was prepared by several procedures. Alkylation of imidazo[4,5-b]pyridine (I) with mesylate (II) in the presence of NaH provided a mixture of the desired compound (III) and its 3-substituted regioisomer (IV), which were separated by column chromatography.
【1】 Itani, H.; et al.; S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa synthesis and structure-activity relationships. 22nd Symp Med Chem (Nov 27 2002, Shizuoka) 2002, Abst 1P-16. |
【2】 Miwa, H.; Yoshida, T.; Shimada, J.; Kuwahara, S.; Nishitani, Y.; S-3578, a new broad-spectrum cephalosporin: I. Synthesis and structure-activity relationships. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-370. |
【3】 Itani, H.; Nishitani, Y.; Irie, T. (Shionogi & Co. Ltd.); Imidazo[4,5-b]pyridiniummethyl-containing cephem cpds. having broad antibacterial spectrum. EP 1134222; WO 0032606 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 44867 | 1H-imidazo[4,5-b]pyridine | C6H5N3 | 详情 | 详情 | |
(II) | 54813 | 3-[(tert-butoxycarbonyl)(methyl)amino]propyl methanesulfonate | C10H21NO5S | 详情 | 详情 | |
(III) | 54814 | tert-butyl 3-(1H-imidazo[4,5-b]pyridin-1-yl)propyl(methyl)carbamate | C15H22N4O2 | 详情 | 详情 | |
(IV) | 54815 | tert-butyl 3-(3H-imidazo[4,5-b]pyridin-3-yl)propyl(methyl)carbamate | C15H22N4O2 | 详情 | 详情 |